St. Jude Medical Receives European CE Mark Approval of Eon Mini Neurostimulator
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced it has received European CE Mark approval of its Eon^™ family of neurostimulators for patients with intractable chronic migraine. Unveiled at the European Headache and Migraine Trust International Congress in London, this approval includes the Eon Mini^™ neurostimulator, which is the world's smallest rechargeable neurostimulator with the longest-lasting battery in its class, and the Eon and EonC^™ neurostimulators. Preceding the Eon family approvals, the company received European CE Mark for its Genesis^™ neurostimulation system, the industry's first regulatory approval for an implanted neurostimulation device to treat patients with intractable chronic migraine.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.